# Portfolio Consistency Audit

This audit verifies consistency across the Phase 14 portfolio materials, existing documentation, and the application codebase.

## 1. Model Architecture
- **Claim:** EfficientNet-B0 (fine-tuned)
- **Verification:** `app.py` clearly loads EfficientNet-B0. The README and all generated reports consistently reference EfficientNet-B0. (No references to MobileNetV2 exist).
- **Status:** PASS

## 2. Evaluation Metrics (Test Set)
- **Claim:** ROC-AUC: 85.37%, Accuracy: 68.47%, Precision: 39.53%, Recall: 90.88%, Specificity: 62.41%, F1: 55.10%
- **Verification:** These metrics match exactly with the `consolidated_evaluation_report.md` and `final_metrics_summary.md`.
- **Status:** PASS

## 3. Confusion Matrix
- **Claim:** TN=734, FP=442, FN=29, TP=289
- **Verification:** Matches exactly with Phase 8 artifacts and `consolidated_evaluation_report.md`.
- **Status:** PASS

## 4. Dataset Splitting
- **Claim:** Lesion-grouped dataset splitting to prevent data leakage.
- **Verification:** Documented consistently across README, SOP, Technical Description, and Demo material.
- **Status:** PASS

## 5. Application Features
- **Claim:** Offline Streamlit app, Grad-CAM, Image Quality heuristics, PBKDF2 authentication, Prediction History.
- **Verification:** All features are implemented in `app.py` and consistently documented.
- **Status:** PASS

## 6. Safety Language
- **Claim:** AI research prototype. Not a medical diagnostic device. Probabilities are statistical outputs.
- **Verification:** Disclaimer exists identically in `app.py`, `README.md`, `consolidated_evaluation_report.md`, and all Phase 14 materials. No clinical claims are made.
- **Status:** PASS

## Conclusion
The portfolio documentation is strictly consistent with the underlying implementation and historical evaluation artifacts. No discrepancies or contradictions were found.
